Skip to main content

Tackling the Achilles Heel of Immunotherapy: Validating imaging biomarkers and targeting the immunological niche of tumour hypoxia

Searching for OpenAIRE data...


The immunocytokine L19-IL2: An interplay between radiotherapy and long-lasting systemic anti-tumour immune responses

Author(s): Nicolle H. Rekers, Veronica Olivo Pimentel, Ala Yaromina, Natasja G. Lieuwes, Rianne Biemans, Catharina M. L. Zegers, Wilfred T. V. Germeraad, Evert J. Van Limbergen, Dario Neri, Ludwig J. Dubois, Philippe Lambin
Published in: OncoImmunology, Issue 7/4, 2017, Page(s) e1414119, ISSN 2162-402X
DOI: 10.1080/2162402X.2017.1414119

Combining radiotherapy with immunotherapy: the past, the present and the future

Author(s): Evert J Van Limbergen, Dirk K De Ruysscher, Veronica Olivo Pimentel, Damiënne Marcus, Maaike Berbee, Ann Hoeben, Nicolle Rekers, Jan Theys, Ala Yaromina, Ludwig J Dubois, Philippe Lambin
Published in: The British Journal of Radiology, Issue 90/1076, 2017, Page(s) 20170157, ISSN 0007-1285
DOI: 10.1259/bjr.20170157

Quality assessment of positron emission tomography scans: recommendations for future multicentre trials

Author(s): Evelyn E. C. de Jong, Wouter van Elmpt, Otto S. Hoekstra, Harry J. M. Groen, Egbert F. Smit, Ronald Boellaard, Philippe Lambin, Anne-Marie C. Dingemans
Published in: Acta Oncologica, Issue 56/11, 2017, Page(s) 1459-1464, ISSN 0284-186X
DOI: 10.1080/0284186X.2017.1346824

Influence of gray level discretization on radiomic feature stability for different CT scanners, tube currents and slice thicknesses: a comprehensive phantom study

Author(s): Ruben T. H. M. Larue, Janna E. van Timmeren, Evelyn E. C. de Jong, Giacomo Feliciani, Ralph T. H. Leijenaar, Wendy M. J. Schreurs, Meindert N. Sosef, Frank H. P. J. Raat, Frans H. R. van der Zande, Marco Das, Wouter van Elmpt, Philippe Lambin
Published in: Acta Oncologica, Issue 56/11, 2017, Page(s) 1544-1553, ISSN 0284-186X
DOI: 10.1080/0284186X.2017.1351624

Feature selection methodology for longitudinal cone-beam CT radiomics

Author(s): Janna E. van Timmeren, Ralph T. H. Leijenaar, Wouter van Elmpt, Bart Reymen, Philippe Lambin
Published in: Acta Oncologica, Issue 56/11, 2017, Page(s) 1537-1543, ISSN 0284-186X
DOI: 10.1080/0284186X.2017.1350285

Radiomics: the bridge between medical imaging and personalized medicine

Author(s): Philippe Lambin, Ralph T.H. Leijenaar, Timo M. Deist, Jurgen Peerlings, Evelyn E.C. de Jong, Janita van Timmeren, Sebastian Sanduleanu, Ruben T.H.M. Larue, Aniek J.G. Even, Arthur Jochems, Yvonka van Wijk, Henry Woodruff, Johan van Soest, Tim Lustberg, Erik Roelofs, Wouter van Elmpt, Andre Dekker, Felix M. Mottaghy, Joachim E. Wildberger, Sean Walsh
Published in: Nature Reviews Clinical Oncology, Issue 14/12, 2017, Page(s) 749-762, ISSN 1759-4774
DOI: 10.1038/nrclinonc.2017.141

Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT

Author(s): Aniek J. G. Even, Bart Reymen, Matthew D. La Fontaine, Marco Das, Arthur Jochems, Felix M. Mottaghy, José S. A. Belderbos, Dirk De Ruysscher, Philippe Lambin, Wouter van Elmpt
Published in: Acta Oncologica, Issue 56/11, 2017, Page(s) 1591-1596, ISSN 0284-186X
DOI: 10.1080/0284186X.2017.1349332

A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy

Author(s): Arthur Jochems, Issam El-Naqa, Marc Kessler, Charles S. Mayo, Shruti Jolly, Martha Matuszak, Corinne Faivre-Finn, Gareth Price, Lois Holloway, Shalini Vinod, Matthew Field, Mohamed Samir Barakat, David Thwaites, Dirk de Ruysscher, Andre Dekker, Philippe Lambin
Published in: Acta Oncologica, Issue 57/2, 2017, Page(s) 226-230, ISSN 0284-186X
DOI: 10.1080/0284186X.2017.1385842

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity

Author(s): Linda Spiegelberg, Stefan J. van Hoof, Rianne Biemans, Natasja G. Lieuwes, Damiënne Marcus, Raymon Niemans, Jan Theys, Ala Yaromina, Philippe Lambin, Frank Verhaegen, Ludwig J. Dubois
Published in: Radiotherapy and Oncology, 2019, ISSN 0167-8140
DOI: 10.1016/j.radonc.2019.06.034